3/24/2021 3:49:47 AM;$XRP.X Take a look at the $BPAX  Project guys. \nWhy not let their AI Bots trade for you??!\nThe amount of money you can make is \uD83D\uDE80\uD83D\uDE80. \n\nThey launch their exchange in 58 days!!\nMessage me for details if you jave questions \n\nThis will be huge!\n Check it out.  Sign up!!\n\nhttps://t.co/SN2OJY3j7P;calgarycraig
3/24/2021 3:38:27 AM;$PIVX.X Take a look at the $BPAX  Project guys. \nWhy not let their AI Bots trade for you??!\nThe amount of money you can make is \uD83D\uDE80\uD83D\uDE80. \n\nThey launch their exchange in 58 days!!\nMessage me for details if you have questions. \n\n Check it out.  Sign up!!\n\nhttps://t.co/SN2OJY3j7P;calgarycraig
3/23/2021 10:12:22 PM;$ANIP ASXC This is the future of surgery with Senhance. No other competitor has this kind of AI technology. Senhance will be the gold standard for surgery in the upcoming years. Minimum buyout value 2-4b+ ($30-$50 per share).  https://youtu.be/dbCffQHncD0;sabinamayer
3/22/2021 1:42:50 PM;$ANIP Negative Zacks article doesn&#39;t even mention the recent acquisition, and refers to opinions formed before the acquisition.;brunoq14
3/20/2021 12:08:57 AM;$ANIP Stock is ready to go. We need some unexpected good news right now!;MarkItUpABuck
3/19/2021 2:58:27 AM;$ANIP Well, we made it to $35 before the selloff brought it back down. I&#39;m relatively optimistic about this company going forward. Let&#39;s complete the merger, get Cortrophin Gel approved, and see what happens.;brunoq14
3/18/2021 3:11:44 PM;$LPCN FYI Technical Breakout in $ANIP, float only 12M shares, mostly owned by institutions.;brunoq14
3/18/2021 3:08:53 PM;$ANIP Stock Consultant: Confirmed Breakout above 33.6. Target Price 37.87.;brunoq14
3/18/2021 12:19:53 PM;ANI Pharmaceuticals Director Patrick Walsh Buys $131,560.00 in $ANIP https://www.marketbeat.com/i/436629;MarketBeatInsiderTrades
3/18/2021 12:01:53 PM;$ANIP Patrick D Walsh bought 4,000 shares [Very High Conviction] www.insider-analysis.com/search_transactions.php?ticker=TABLE_ANIP;Insider_Analysis
3/18/2021 9:05:01 AM;$ANIP: New SEC filing on Director, PATRICK D WALSH: https://www.sec.gov/Archives/edgar/data/1023024/000141588921001560/xslF345X03/form4-03172021_040314.xml;FilingsVille
3/17/2021 11:59:45 PM;$ANIP [15s. delayed] filed SEC form 4: Director Walsh Patrick D: \nAcquired 4,000 of Common Stock at price $32.89 on 2021-03-15, increased  https://s.flashalert.me/4eyyT;fla
3/17/2021 11:58:14 PM;ANI Pharmaceuticals insider just picked up 4,000 shares  http://www.conferencecalltranscripts.org/summary/?id=9057816 $ANIP;cctranscripts
3/17/2021 11:57:02 PM;Insider Patrick D Walsh reports buying 4,000 shares of $ANIP for a total cost of $131,555.20 https://fintel.io/n/us/anip/walsh-patrick-d?utm_source=stocktwits.com&amp;utm_medium=Referral&amp;utm_campaign=insider;risenhoover
3/17/2021 11:56:28 PM;$ANIP \uD83D\uDCDC SEC Form 4: D Patrick Walsh bought $131,555 worth of Common Stock (4,000 units at $32.89), increasing direct ownership by 11% to 39,096 units\n\nhttps://quantisnow.com/insight/524336?s=s\n\n#majorpharmaceuticals #healthcare;Quantisnow
3/17/2021 11:56:24 PM;$ANIP $131,560.00 of shares acquired by Walsh Patrick D (Director), reported in a new form 4 filed with the SEC  \n\nhttps://newsfilter.io/a/683d8218f276f860f297751b7ee8e17c;Newsfilter
3/17/2021 2:20:30 PM;Upcoming ER:  $ANIP on 2021-03-09 at 6:50:00 |\uD83D\uDCE9\uD83D\uDCE9  Free Daily ER Calendar via Email, Goto https://earningscalendar.io  \uD83C\uDFAF;earningscalendario
3/17/2021 6:48:53 AM;Upcoming ER:  $ANIP on 2021-03-09 at 6:50:00 |\uD83D\uDCE9\uD83D\uDCE9  Free Daily ER Calendar via Email, Goto https://earningscalendar.io  \uD83C\uDFAF;earningscalendario
3/17/2021 5:01:37 AM;Upcoming ER:  $ANIP on 2021-03-09 at 6:50:00 |\uD83D\uDCE9\uD83D\uDCE9  Free Daily ER Calendar via Email, Goto https://earningscalendar.io  \uD83C\uDFAF;earningscalendario
3/15/2021 4:54:25 PM;$ANIP Stock Consultant: Breakout Watch at 33.51, Target Price 37.77;brunoq14
3/15/2021 3:45:26 PM;$ANIP  coming out of a monster year long base... over 34 looks good with small resistance at 36 and 40;net0trader
3/12/2021 1:56:13 PM;Cantor Fitzgerald Sets ANI Pharmaceuticals FY2021 Earnings Estimates at $2.86 EPS. https://www.marketbeat.com/x/1002171 $ANIP;MarketBeat
3/11/2021 10:07:19 PM;$ANIP Cortrophin Gel to be resubmitted Q2. Reason for delay? They finally wised up and scheduled a Type A meeting with the FDA, with whom they have had subsequent consultations. Now two potential growth sources: acquisition and Cortrophin.;brunoq14
3/11/2021 4:58:55 PM;$ANIP &quot;We expect the transaction will be immediately accretive to our adjusted EBITDA. Upon closing of the transaction, our strengthened pro forma capital structure, including the new senior credit facilities underwritten by Truist Securities and the PIPE from Ampersand Capital Partners will enable us to facilitate long-term growth,&quot; concluded ANI CEOLalwani https://thefly.com/n.php?id=3262711;kshonstocks
3/11/2021 4:56:49 PM;Take a careful look at $ANIP zacks estimate for next yr is $6.20;kshonstocks
3/11/2021 3:00:41 PM;Last10K highlighted 62 positive and negative remarks in $ANIP&#39;s 10-K filed today. See them in the Annual Report: https://last10k.com/sec-filings/ANIP/0001023024-21-000007.htm?utm_source=stocktwits&amp;utm_medium=forum&amp;utm_campaign=sentiment&amp;utm_term=anip;Last10K
3/11/2021 1:38:02 PM;$ANIP just filed a 10-K Annual Report with 78 sections and 7 exhibits. Access them all or just read their earnings: https://last10k.com/sec-filings/anip/0001023024-21-000007.htm?utm_source=stocktwits&amp;utm_medium=forum&amp;utm_campaign=10KQ2040F&amp;utm_term=anip;Last10K
3/11/2021 1:34:24 PM;ANI Pharmaceuticals just filed its Annual report [Section 13 and 15(d), not http://www.conferencecalltranscripts.org/include?location=http://www.sec.gov/Archives/edgar/data/1023024/000102302421000007/0001023024-21-000007-index.htm $ANIP;cctranscripts
3/11/2021 1:34:06 PM;$ANIP / ANI Pharmaceuticals files form 10-K https://fintel.io/sf/us/anip?utm_source=stocktwits.com&amp;utm_medium=Referral&amp;utm_campaign=filing;risenhoover
